A Phase II Trial of Cabozantinib With Patients With Refractory GCTs
A Phase II Trial of Cabozantinib With Patients With Refractory GCTs
Active, not recruiting · NCT04876456 · Registry updated 2026-01-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase II Trial of Cabozantinib With Patients With Refractory GCTs | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Nonseminomatous germ cell tumor, germinoma, neoplasm, nongerminomatous germ cell tumor, ovarian germ cell tumor, seminoma | Active, not recruiting | Phase 2 | 2026-01-15 | NCT04876456 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Exelixis | 77 |
| JDS Foundation Testis Cancer Clinical Trials Support Fund | 2 |
| Jennifer King | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Indiana University Melvin & Bren Simon Cancer Center | Indianapolis | United States | 6 |